Literature DB >> 19515628

Long-term outcomes of augmentation enterocystoplasty with an ileal segment in patients with spinal cord injury.

Jing-Liang Chen1, Hann-Chorng Kuo.   

Abstract

BACKGROUND/
PURPOSE: Neurogenic bladder has been considered a relative contraindication for augmentation enterocystoplasty (AE), but neurogenic voiding dysfunction has become a common indication for AE. We evaluated long-term outcomes in patients with spinal cord injury (SCI) who underwent AE with an ileal segment.
METHODS: We reviewed retrospectively 40 consecutive adults with SCI who underwent AE. The outcomes assessed included bladder capacity and compliance, incidence of stone formation, upper urinary tract status, urinary tract infection (UTI), need for intermittent catheterization, urinary incontinence, postoperative morbidity, persistent loose stools, and metabolic malabsorption.
RESULTS: Four women and 36 men aged 20-56 years (mean, 36.3 +/- 8.8 years), with a mean follow-up period of 7.8 +/- 0.6 years were included. Twenty-nine (72.5%) patients had detrusor overactivity and the other 11 had detrusor underactivity. Simple AE was performed in 27 patients, AE with ureteral reimplantation in seven, and continent diversion by enterocystoplasty with an abdominal stoma in six. The mean bladder capacity increased from 115 +/- 16.3 to 513 +/- 31.4 mL after the operation. Four patients (10%) could void spontaneously and 29 (72.5%) had to perform clean intermittent catheterization to empty their bladders. Twenty-six patients (65%) had episodes of UTI. Three patients (7.5%) experienced de novo diarrhea that required antispasmodics. Long-term complications included urinary incontinence in four (10%) patients, reservoir calculi in 13 (32.5%) and new-onset upper tract stones in nine (22.5%).
CONCLUSION: AE with an ileal segment provides effective and safe therapeutic outcomes in SCI patients. However, problems with UTI, reservoir calculi and new-onset upper tract urolithiasis still need to be solved.

Entities:  

Mesh:

Year:  2009        PMID: 19515628     DOI: 10.1016/S0929-6646(09)60095-4

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  11 in total

Review 1.  Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011.

Authors:  Anna P Malykhina; Jean-Jacques Wyndaele; Karl-Erik Andersson; Stefan De Wachter; Roger R Dmochowski
Journal:  Neurourol Urodyn       Date:  2012-02-29       Impact factor: 2.696

2.  Midterm outcomes of protection for upper urinary tract function by augmentation enterocystoplasty in patients with neurogenic bladder.

Authors:  Limin Liao; Fan Zhang; Guoqing Chen
Journal:  Int Urol Nephrol       Date:  2014-07-23       Impact factor: 2.370

Review 3.  Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management.

Authors:  Arun Sahai; Eduardo Cortes; Jai Seth; Muhammad Shamim Khan; Jalesh Panicker; Cornelius Kelleher; Thomas M Kessler; Clare J Fowler; Prokar Dasgupta
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

4.  Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury.

Authors:  A Balanca; A Even; C Malot; E Chartier-Kastler; P Denys; C Joussain
Journal:  World J Urol       Date:  2022-06-10       Impact factor: 3.661

Review 5.  Neurogenic bladder in spinal cord injury patients.

Authors:  Waleed Al Taweel; Raouf Seyam
Journal:  Res Rep Urol       Date:  2015-06-10

6.  Histologic and functional outcomes of small intestine submucosa-regenerated bladder tissue.

Authors:  Yiming Wang; Limin Liao
Journal:  BMC Urol       Date:  2014-08-23       Impact factor: 2.264

7.  Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction.

Authors:  Yuan-Hong Jiang; Sheng-Fu Chen; Hann-Chorng Kuo
Journal:  Int Neurourol J       Date:  2020-12-31       Impact factor: 2.835

Review 8.  Current Applications and Future Directions of Bioengineering Approaches for Bladder Augmentation and Reconstruction.

Authors:  Xuesheng Wang; Fan Zhang; Limin Liao
Journal:  Front Surg       Date:  2021-06-18

9.  Long-term Outcomes of Augmentation Enterocystoplasty in Patients With End-Stage Bladder Diseases: A Single-Institute Experience Involving 102 Patients.

Authors:  Shu-Yu Wu; Yuan-Hong Jiang; Hann-Chorng Kuo
Journal:  Int Neurourol J       Date:  2017-06-21       Impact factor: 2.835

10.  Video-Urodynamic Characteristics and Predictors of Switching from Botulinum Neurotoxin a Injection to Augmentation Enterocystoplasty in Spinal Cord Injury Patients.

Authors:  Chih-Chieh Lin; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2022-01-10       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.